Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0165
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
Emmaus Life Sciences Employees
As of December 31, 2024, Emmaus Life Sciences had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees decreased by 20 or -36.36% compared to the previous year.
Employees
35
Change (1Y)
-20
Growth (1Y)
-36.36%
Revenue / Employee
$475,800
Profits / Employee
-$184,371
Market Cap
1.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Emmaus Life Sciences News
- 5 months ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire
- 8 months ago - Emmaus Life Sciences Reports Quarterly Financial Results - PRNewsWire
- 9 months ago - Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer - PRNewsWire
- 10 months ago - Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program - PRNewsWire
- 10 months ago - Emmaus Life Sciences Reports 2023 Financial Results - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Delayed Filing of Annual Report - PRNewsWire
- 1 year ago - Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Q3 2023 Financial Results - PRNewsWire